Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bonds

Oxford Lane Capital Distributes First Post-Split Dividend Payment

Robert Sasse by Robert Sasse
September 30, 2025
in Bonds, Dividends, ETF
0
Oxford Lane Capital Stock
0
SHARES
96
VIEWS
Share on FacebookShare on Twitter

Shareholders of Oxford Lane Capital received a significant dividend distribution today, marking the initial payment following the company’s recent reverse stock split. The closed-end fund distributed $0.45 per share, representing the split-adjusted equivalent of the previously announced $0.09 payout.

This distribution follows the 1:5 reverse stock split executed on September 8, which consolidated shares to potentially increase the per-share price and attract institutional investors while maintaining shareholders’ proportional ownership stakes.

Revised Dividend Schedule

The board of directors has adjusted all previously declared distributions to align with the new share structure. The updated dividend calendar now includes:

  • September 30, 2025: $0.45 per share (paid today)
  • October 31, 2025: $0.40 per share (record date: October 17)
  • November 30, 2025: $0.40 per share (record date: November 14)
  • December 31, 2025: $0.40 per share (record date: December 17)

These amounts correspond to the split-adjusted equivalents of the original $0.09 and $0.08 distributions declared before the reverse split. The company clarified that no fractional shares were issued, with shareholders instead receiving cash payments for fractional interests.

Should investors sell immediately? Or is it worth buying Oxford Lane Capital?

Investment Strategy and Performance Metrics

Oxford Lane Capital maintains its specialized focus on investments in both debt and equity tranches of collateralized loan obligation (CLO) vehicles. The fund’s strategy continues to emphasize CLO equity investments, which generated approximately $117.4 million in investment income during the first fiscal quarter ending June 30, 2025.

Recent financial metrics demonstrate the portfolio’s performance: the weighted average cash dividend yield from CLO equity investments reached 21.6% at current cost as of June 30, 2025, compared to 20.5% in the prior quarter. The net asset value stood at $4.12 per share (pre-split) as of June 30, 2025, versus $4.32 per share as of March 31, 2025.

Dividend Sustainability Considerations

The increased per-share dividend amounts reflect mathematical adjustments following the reverse split rather than an actual increase in distribution rates. Oxford Lane’s capacity to maintain these dividends depends on the continuing performance of its CLO investment portfolio and broader conditions in the leveraged loan market.

With core net capital income of $0.24 per share (pre-split) during the first fiscal quarter, management continues to emphasize that taxable income may differ substantially from GAAP financial measures. The next earnings report and potential dividend declarations are anticipated in the coming months as Oxford Lane approaches its fiscal year-end.

Ad

Oxford Lane Capital Stock: Buy or Sell?! New Oxford Lane Capital Analysis from February 7 delivers the answer:

The latest Oxford Lane Capital figures speak for themselves: Urgent action needed for Oxford Lane Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Oxford Lane Capital: Buy or sell? Read more here...

Tags: Oxford Lane Capital
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Blue Ridge Bankshares Stock
Banking & Insurance

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

February 7, 2026
Claros Mortgage Trust Stock
Analysis

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

February 7, 2026
Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Next Post
Bruker Stock

Analyst Sentiment Cools on Bruker Amid Disappointing Earnings and Convertible Bond Plan

Vertiv Stock

Analyst Upgrade Fuels Vertiv's Market Momentum

Hecla Mining Stock

Hecla Mining Shares Surge as Silver Producer Gains Momentum

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com